Loading...
Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed
Pemetrexed (ALIMTA, LY231514, MTA) is a novel multitargeted antifolate that is currently approved for the treatment of metastatic nonsmall cell lung cancer (NSCLC). Recent evidence reveals that the drug’s efficacy is limited to nonsquamous lung cancer histology. As we further understand the drug’s m...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2009
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3513199/ https://ncbi.nlm.nih.gov/pubmed/23226032 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|